USFDA19 Feb 2026, 08:47 pm
USFDA Inspection Closed at Zydus Injectable Plant with No Observations
AI Summary
The US Food and Drug Administration (USFDA) conducted a Pre Approval Inspection (PAI) for Injectable Medical Devices at Zydus Lifesciences Ltd.’s Unit 9 facility located at Zydus Biotech Park, Changodar, Ahmedabad from 16th to 19th February, 2026. The inspection closed with NIL observations. This disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- USFDA conducted PAI for Injectable Medical Devices at Zydus Lifesciences Ltd.’s Unit 9 facility in Ahmedabad
- The inspection was conducted from 16th to 19th February, 2026
- The inspection closed with NIL observations